Treatment Avenues in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Split-gender Pharmacogenomic Study of Gene-expression Modules.
Jeffrey, Mary G, Nathanson, Lubov, Aenlle, Kristina et al.·Clinical therapeutics·2019
Researchers studied blood samples from 33 ME/CFS patients and 21 healthy people to look for differences in how their genes were working. They found that ME/CFS appears to involve problems with the immune system (the body's defense mechanism) and how cells produce energy. By matching these gene differences with existing FDA-approved drugs, they identified immunosuppressant medications as potential candidates that might help reduce ME/CFS symptoms.